Arthneeti
PS

Privi Speci.

Q1 FY27Chemicals & Petrochemicals

Privi Speci. Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹3,450
Market cap₹13.6K Cr
P/E38.9
Updated25 Aug 2026
Read4 min read

What the Q1 FY27 call signalled

3 of 4 strong

RevenueGood growth
MarginMargins steady
CapexCapex planned
FundraiseFundraise planned

The short version

The company targets achieving Rs. Privi Speciality Chemicals aims for a revenue target of Rs.

From Privi Speci.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Good growth
  • The company targets achieving Rs. 5,000 crore in revenue and over Rs. 1,000 crore in EBITDA within the next 3-4 years, representing approximately 2x growth.
  • They expect a 20% CAGR in revenue while maintaining similar EBITDA margins.
  • Capacity expansions from 48,000 metric tons to 66,000 metric tons by September 2027 will support growth.
  • New specialty molecules including those based on furfural (from corn cob) will add about Rs. 1,000 crore+ to revenue.
  • The company’s JV PRIGIV is expected to contribute meaningfully and scale further.
  • Operational efficiencies and improved product mix are expected to sustain margins near 25%.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Privi Speci. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Ongoing Phase-1 CAPEX to expand production capacity from 48,000 to 54,000 metric tons, expected to be commercialized by September 2026.
  • Planned Phase-2 and Phase-3 CAPEX for multi-specialty aroma chemicals project, targeting capacity expansion to 66,000 metric tons by September 2027.
  • Total CAPEX for FY26–FY28 estimated at around Rs. 850 to 900 crores to complete Phase-2 and Phase-3.
  • Rs. 300 crore CAPEX for existing products slightly delayed, now expected September 2026.
  • Additional Rs. 300 crore CAPEX each for new specialty products including Maltol and Musk T.
  • Joint Venture PRIGIV expanding with an additional Rs. 50 crore equity investment for next-phase expansion.

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Privi Speci. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided from Privi Speciality Chemicals Limited's Q1 FY27 earnings call does not explicitly mention the current or expected order book or pending orders. However, some related insights include: - The company is on track to achieve its vision of Rs. 5,000 crores in revenue and Rs. 1,000 crores plus EBITDA over the next 3-4 years. - Strong demand sustained across key end-user industries supports growth. - The PRIGIV JV is progressing well, contributing about Rs. 18 crores in revenue with a 14%-15% EBITDA margin.

2 more points management made on order book & pipeline

Privi Speci. — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹722 Cr, net profit ₹94 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Privi Speci.'s management said in earlier quarters

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Privi Speci. Q1 FY27 results?

The company targets achieving Rs. Privi Speciality Chemicals aims for a revenue target of Rs.

What is Privi Speci. share price analysis?

Privi Speci. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 38.9 with a market cap of ₹13,593 Cr. Investors should review the full earnings analysis for detailed insights.

Is Privi Speci. planning capital expenditure?

Ongoing Phase-1 CAPEX to expand production capacity from 48,000 to 54,000 metric tons, expected to be commercialized by September 2026.

Keep Privi Speci. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.